Suspended animation for delayed resuscitation

Current Opinion in Anaesthesiology

Volumn 15, Issue 2, 2002, Pages 203-210

  Safar, Peter J ^a   Tisherman, Samuel A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN FUNCTION; BRAIN OXYGEN CONSUMPTION; CARDIOPULMONARY BYPASS; CELL VIABILITY; CRYOPRESERVATION; DOG; HEART ARREST; HEART PRESERVATION; HEAT EXCHANGE; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SUSPENDED ANIMATION FOR DELAYED RESUSCITATION; TREATMENT INDICATION;

EID: 0036111195     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200204000-00010     Document Type: Review

References (79)

1. From control of airway and breathing to cardiopulmonary-cerebral resuscitation
2. Upper airway obstruction in the unconscious patient
3. Artificial respiration by mouth-to-mask method. A study of the respiratory gas exchange of paralyzed patients ventilated by operator's expired air
4. A comparison of the mouth-to-mouth and mouth-to-airway methods of artificial respiration with the chest-pressure armlift methods
5. Closed-chest cardiac massage
6. Ventilation and circulation with closed chest cardiac massage in man
7. Four-minute limit for cardiac resuscitation
8. Cardiac arrest and resuscitation: A tale of 29 cities
9. Improving survival from sudden cardiac arrest: The 'chain of survival' concept
10. Guidelines 2000 for CPR and emergency cardiovascular care
11. Cardiac resuscitation
12. Cardiopulmonary-cerebral resuscitation. Letter to the editor Eisenberg and Mengert
13. Life supporting first aid (LSFA) training of the public. Review and recommendations
14. Future directions for resuscitation research. V. Ultra-advanced life support
15. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest
16. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest
17. A randomized clinical trial of high dose epinephrine during cardiac arrest
18. A comparison of blood flow during external and internal cardiac massage in man
19. Cerebral preservation during cardiopulmonary resuscitation in dogs
20. Emergency cardiopulmonary bypass for resuscitation from prolonged cardiac arrest
21. Cardiac resuscitability with cardiopulmonary bypass after increasing ventricular fibrillation times in dogs
22. Feasibility of emergency cardiopulmonary bypass for resuscitation from CPR-resistant cardiac arrest: A preliminary report
23. Suspended animation for delayed resuscitation from prolonged cardiac arrest that is unresuscitable by standard cardiopulmonary-cerebral resuscitation
24. The resuscitation greats. Vladimir A. Negovsky the father of 'reanimatology'
25. Arterial versus venous transfusion in cardiac arrest from exsanguination
26. Exsanguination versus ventricular fibrillation cardiac arrest in dogs: Comparison of neurologic outcome: Preliminary data
27. Suspended animation for delayed resuscitation
28. Survival after emergency department thoracotomy: Review of published data from the past 25 years
29. Cerebral resuscitation from cardiac arrest
30. Resuscitation from clinical death: Pathophysiologic limits and therapeutic potentials
31. Regional prevalence and distribution of ischemic neurons in dog brains 96 hours after cardiac arrest of 0 to 20 minutes
32. Complete global myocardial ischemia in dogs
33. Mild cerebral hypothermia during and after cardiac arrest improves neurologic outcome in dogs
34. Improved cerebral resuscitation from cardiac arrest in dogs with mild hypothermia plus blood flow promotion
35. Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury
36. Treatment of comatose survivors of prehospital cardiac arrest with induced hypothermia
37. The Hypothermia After Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest
38. Therapeutic hypothermia after cardiac arrest
39. Effects of total circulatory standstill in profound hypothermia
40. Whole body protection during three hours of total circulatory arrest: An experimental study
41. The protective effect of profound hypothermia on the canine central nervous system during one hour of circulatory arrest
42. Prolonged suspended animation in puppies
43. Survival of hypothermic dogs after 2-h circulatory arrest
44. Further studies on opiods and hibernation: Delta opiod receptor ligand selectively induced hibernation in summer-active ground squirrels
45. Therapeutic deep hypothermic circulatory arrest in dogs: A resuscitation modality for hemorrhagic shock with 'irreparable' injury
46. Profound hypothermia (<10°C) compared with deep hypothermia (15°C) improves neurologic outcome in dogs after two hours' circulatory arrest induced to enable resuscitative surgery
47. Profound hypothermia does, and an organ preservation solution does not, improve neurologic outcome after therapeutic circulatory arrest of 2 h in dogs
48. Cardiopulmonary bypass without systemic anticoagulation for therapeutic hypothermic circulatory arrest during hemorrhagic shock in dogs
49. 'Suspended animation' research for otherwise infeasible resuscitative traumatologic surgery
50. Complete recovery after normothermic hemorrhagic shock and profound hypothermic circulatory arrest of 60 minutes in dogs
51. Hypothermic aortic arch flush for preservation during exsanguination cardiac arrest of 15 minutes in dogs
52. Rapid induction of mild cerebral hypothermia by cold aortic flush achieves normal recovery in a dog outcome model with 20-minute exsanguination cardiac arrest
53. Rapid hypothermic aortic flush can achieve survival without brain damage after 30 min cardiac arrest in dogs
54. Intact survival of 60, 90, and 120 min cardiac arrest in dogs with 10°C cerebral preservation by cold aortic flush
55. Mild hypothermic aortic arch flush improves neurologic outcome from exsanguination cardiac arrest in dogs
56. Delayed intra-ischemic aortic cold flush for preservation during prolonged cardiac arrest in dogs
57. Liver damage during prolonged cardiac arrest (CA) in dogs
58. Exploration of pharmacologic aortic arch flush strategies for rapid induction of suspended animation (SA) (cerebral preservation) during exsanguination cardiac arrest (ExCA) of 20 min in dogs
59. Adenosine by aortic flush fails to augment the brain preservation effect of mild hypothermia during exsanguination cardiac arrest in dogs. An exploratory study
60. Thiopental and phenytoin by aortic arch flush for cerebral preservation during exsanguination cardiac arrest of 20 minutes in dogs. An exploratory study
61. Fructose-1,6-bisphosphate and MK801 by aortic arch flush for cerebral preservation during exsanguination cardiac arrest of 20 minutes in dogs. An exploratory study
62. Antioxidant Tempol enhances hypothermic cerebral preservation during prolonged cardiac arrest in dogs
63. Novel solutions for intra-ischemic aortic cold flush for preservation during 30 min cardiac arrest in dogs
64. Intact survival of 120 min cardiac arrest at 10°C in dogs. Cerebral preservation by cold aortic flush
65. Comparison of Unisol with Euro-Collins solution as a vehicle solution for cryoprotectants
66. Induced hypothermia during emergency department thoracotomy: An animal model
67. A new solution for life without blood: Asanguinous low-flow perfusion of a whole-body perfusate during 3 hours of cardiac arrest and profound hypothermia
68. Ultraprofound hypothermia combined with blood substitution: A new protocol for extending the safe limits of cardiac arrest for up to three hours
69. Behavioral effects of autocerebral perfusion, hypothermia and arrest of cerebral blood flow in the Rhesus monkey
70. Ultraprofound cerebral hypothermia and blood substitution with an acellular synthetic solution maintains neuronal viability in rat hippocampus
71. Evidence for two modes of hypothermia damage in five cell lines
72. Veno-venous extra-corporeal blood cooling for rapid induction of mild hypothermia in dogs
73. Cooling for acute ischemic brain damage (cool aid): An open pilot study of induced hypothermia in acute ischemic stroke